H
Hanne Christensen
Researcher at University of Copenhagen
Publications - 207
Citations - 56368
Hanne Christensen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Stroke & Population. The author has an hindex of 51, co-authored 190 publications receiving 41935 citations. Previous affiliations of Hanne Christensen include Gentofte Hospital & Copenhagen University Hospital.
Papers
More filters
Journal Article
Benzodiazepines in blood samples with 0 alcohol content sent to the Institute of Forensic Chemistry
TL;DR: It is feared, that the drug problem in connection with driving will be forgotten, all the while it is increasing steadily, because of the known difficulties in instituting proceedings against drivers influenced by drugs.
Journal ArticleDOI
Implementation of the Stroke Action Plan for Europe 2018-2030 during coronavirus disease-2019.
TL;DR: The COVID-19 pandemic has challenged organized care, diverged attention from stroke and necessitated a novel approach to the implementation program because of the continued need for social distancing and reduced travelling, so the Action Plan will rely on online meetings and resources as it is yet unforeseeable when things will return to normal.
Journal ArticleDOI
A computer-based method for precise detection and calculation of affected skin areas
Sille Mølvig Henriksen,Janus Damm Nybing,Rasmus Bouert,Inger Havsteen,Anders F. Christensen,Kenneth Jensen,Hanne Christensen,Jens Børglum +7 more
TL;DR: A method to obtain reproducible and comparable results concerning extension of a specific skin area, unaffected by individual differences in body surface area is described and validated.
Journal ArticleDOI
Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
Agnethe Eltoft,Tom Wilsgaard,Melinda B Roaldsen,M-H Soyland,Erik Lundström,Jesper Petersson,Bent Indredavik,Jukka Putaala,Hanne Christensen,Janika Kõrv,Dalius Jatuzis,Stefan T. Engelter,Gian Marco De Marchis,David J. Werring,Thompson G. Robinson,A. Tveiten,Ellisiv B. Mathiesen +16 more
TL;DR: The TWIST trial as mentioned in this paper is a randomized controlled trial of intravenous tenecteplase 0.25 mg/kg and standard care versus standard care alone (no thrombolysis) in patients with acute ischemic stroke and can be treated within 4.5 h of wakening based on non-contrast CT findings.
Journal ArticleDOI
Sex-Differences in Oral Anticoagulant-Related Intracerebral Hemorrhage
Josefine Liv Gilling Grundtvig,Christian Ovesen,Thorsten Steiner,Cheryl Carcel,David Gaist,Louisa M. Christensen,Jacob Marstrand,Per Meden,Sverre Rosenbaum,Helle K. Iversen,Christina Kruuse,Thomas Christensen,Karen Lehrmann Ægidius,Inger Havsteen,Hanne Christensen +14 more
TL;DR: This study supports the presence of sex-differences in risk factors and care but not in presentation and outcomes in men and women admitted with OAC-related ICH while no significant differences were observed in comorbidity burden, stroke severity, or hematoma volume.